1. Home
  2. CYTK vs ESI Comparison

CYTK vs ESI Comparison

Compare CYTK & ESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • ESI
  • Stock Information
  • Founded
  • CYTK 1997
  • ESI 1922
  • Country
  • CYTK United States
  • ESI United States
  • Employees
  • CYTK N/A
  • ESI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • ESI Major Chemicals
  • Sector
  • CYTK Health Care
  • ESI Industrials
  • Exchange
  • CYTK Nasdaq
  • ESI Nasdaq
  • Market Cap
  • CYTK 4.6B
  • ESI 5.5B
  • IPO Year
  • CYTK 2004
  • ESI N/A
  • Fundamental
  • Price
  • CYTK $53.01
  • ESI $26.22
  • Analyst Decision
  • CYTK Buy
  • ESI Strong Buy
  • Analyst Count
  • CYTK 15
  • ESI 9
  • Target Price
  • CYTK $75.57
  • ESI $27.78
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • ESI 1.6M
  • Earning Date
  • CYTK 11-05-2025
  • ESI 10-27-2025
  • Dividend Yield
  • CYTK N/A
  • ESI 1.24%
  • EPS Growth
  • CYTK N/A
  • ESI 23.17
  • EPS
  • CYTK N/A
  • ESI 0.99
  • Revenue
  • CYTK $85,738,000.00
  • ESI $2,488,100,000.00
  • Revenue This Year
  • CYTK $330.96
  • ESI $2.41
  • Revenue Next Year
  • CYTK $73.41
  • ESI $5.92
  • P/E Ratio
  • CYTK N/A
  • ESI $26.18
  • Revenue Growth
  • CYTK 2635.74
  • ESI 5.41
  • 52 Week Low
  • CYTK $29.31
  • ESI $16.77
  • 52 Week High
  • CYTK $59.39
  • ESI $29.78
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 77.96
  • ESI 64.97
  • Support Level
  • CYTK $35.22
  • ESI $24.44
  • Resistance Level
  • CYTK $50.22
  • ESI $25.99
  • Average True Range (ATR)
  • CYTK 2.29
  • ESI 0.54
  • MACD
  • CYTK 1.64
  • ESI 0.01
  • Stochastic Oscillator
  • CYTK 94.73
  • ESI 100.00

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.

Share on Social Networks: